Home » Medical Devices » KSA Peripheral Vascular Devices Market

KSA Peripheral Vascular Devices Market By Type (Angioplasty Balloons, Angioplasty Stents, Catheters, Guidewires, Others); By End-user (Hospitals, Ambulatory Surgical Centers, Specialty Clinics) – Growth, Share, Opportunities & Competitive Analysis, 2024 – 2032

Price: $2699

Published: | Report ID: 71082 | Report Format : PDF
REPORT ATTRIBUTE DETAILS
Historical Period 2019-2022
Base Year 2023
Forecast Period 2024-2032
KSA Peripheral Vascular Devices Market Size 2023 USD 18.47 million
KSA Peripheral Vascular Devices Market, CAGR 4.00%
KSA Peripheral Vascular Devices Market Size 2032 USD 25.29 million

Market Overview

The KSA Peripheral Vascular Devices market is projected to grow from USD 18.47 million in 2023 to USD 25.29 million by 2032, at a compound annual growth rate (CAGR) of 4.00%.

The KSA Peripheral Vascular Devices market is driven by an increasing prevalence of vascular diseases, particularly among the aging population, which heightens the demand for effective treatment solutions. Advancements in medical technologies, such as minimally invasive procedures, are also contributing to market growth by offering better patient outcomes and faster recovery times. The rise in healthcare infrastructure and government initiatives to improve healthcare services in Saudi Arabia further support the market expansion. Additionally, the growing awareness about peripheral vascular conditions and the benefits of early diagnosis and treatment is encouraging patients to seek professional care. Trends in the market include the adoption of advanced devices like atherectomy systems, balloon catheters, and stents, which are gaining traction for their ability to treat peripheral artery diseases more effectively. The increasing focus on precision medicine and personalized care also plays a significant role in driving market growth.

The KSA peripheral vascular devices market is driven by key players such as Medtronic plc, Abbott Laboratories, Boston Scientific Corporation, and Terumo Corporation, among others. These companies dominate the market with their innovative product offerings, ranging from angioplasty balloons to stents and guidewires, addressing the growing demand for advanced vascular treatments in Saudi Arabia. Geographically, the market is concentrated in major urban areas, particularly the Central Region (Riyadh), which hosts numerous healthcare facilities and specialized centers for vascular care. The Eastern Region, including Dammam and Khobar, also sees strong demand due to its economic growth and improving healthcare infrastructure. The Western and Southern Regions are witnessing gradual market expansion, supported by government initiatives aimed at enhancing healthcare access in underserved areas. These regions provide opportunities for market players to introduce their advanced devices and improve the treatment options for peripheral vascular diseases.

Design Element 2

Access crucial information at unmatched prices!

Request your free sample report today & start making informed decisions powered by Credence Research!

Download Free Sample

CTA Design Element 3

Market Insights

  • The KSA peripheral vascular devices market was valued at USD 18.47 million in 2023 and is projected to reach USD 25.29 million by 2032, growing at a CAGR of 4.00%.
  • Increasing prevalence of peripheral vascular diseases, particularly among the aging population, is a key driver of market growth.
  • Advancements in minimally invasive procedures and the development of drug-eluting devices are shaping market trends.
  • High treatment costs associated with advanced devices and limited reimbursement options act as market restraints.
  • Key players such as Medtronic, Abbott, Boston Scientific, and Terumo Corporation dominate the market with innovative offerings.
  • The Central and Eastern regions lead the market, with Riyadh and Dammam being key hubs for healthcare infrastructure.
  • Growing awareness about vascular diseases and government healthcare initiatives are driving the expansion of peripheral vascular care across Saudi Arabia.

Market Drivers

Government Initiatives and Healthcare Infrastructure Development

The Saudi government’s commitment to improving healthcare services has significantly contributed to the growth of the peripheral vascular devices market. Under the Vision 2030 initiative, healthcare infrastructure in the kingdom is being expanded and upgraded. For instance, the Saudi government has allocated over $65 billion to develop the country’s healthcare infrastructure, including the establishment of specialized vascular care centers. This includes the development of specialized vascular care centers, which will increase access to peripheral vascular treatments. Additionally, government-funded healthcare programs are making treatment more accessible to a broader population, further driving the demand for peripheral vascular devices.

Growing Awareness and Early Diagnosis

Increasing public awareness regarding vascular diseases and the importance of early diagnosis is another critical driver of market growth in Saudi Arabia. The government and private healthcare providers are investing in awareness campaigns and educational programs to highlight the risks of untreated peripheral vascular conditions. For instance, the Saudi Heart Association, in collaboration with the American College of Cardiology, has launched educational programs to prevent cardiovascular diseases and promote early diagnosis. As a result, more individuals are seeking medical attention at an early stage, increasing the adoption of peripheral vascular devices for timely intervention and treatment.

Rising Prevalence of Vascular Diseases

The increasing incidence of peripheral vascular diseases (PVD), particularly in the aging population of Saudi Arabia, is a major driver of the KSA peripheral vascular devices market. As lifestyle-related risk factors like diabetes, hypertension, and smoking continue to rise, the prevalence of conditions such as peripheral artery disease (PAD) is expected to increase. This growing patient pool demands efficient treatment options, driving the demand for advanced peripheral vascular devices like stents, balloon catheters, and atherectomy systems.

Technological Advancements in Medical Devices

Technological innovation plays a pivotal role in the growth of the peripheral vascular devices market in Saudi Arabia. Minimally invasive devices have revolutionized the treatment of vascular diseases, offering benefits like shorter recovery times, reduced complications, and less patient discomfort. Advances in materials, such as drug-eluting stents and bioresorbable devices, are further enhancing the efficacy of treatment, leading to improved patient outcomes. The ongoing development of next-generation devices is expected to continue driving market demand.

Market Trends

Increasing Focus on Personalized Medicine

Personalized medicine is emerging as a key trend in the treatment of peripheral vascular diseases in Saudi Arabia. This approach involves tailoring treatment plans based on an individual’s genetic makeup, lifestyle, and specific health conditions. As advancements in diagnostic technologies enable more precise diagnoses, healthcare providers are increasingly able to offer customized treatments. For instance, King Faisal Specialist Hospital & Research Centre has made considerable progress in personalized medicine by conducting pharmacogenetic tests on over 1,500 patients. This trend is leading to the development of more specialized and patient-specific peripheral vascular devices, further enhancing treatment efficacy and patient satisfaction.

Shift Toward Minimally Invasive Procedures

One of the prominent trends in the KSA peripheral vascular devices market is the growing preference for minimally invasive procedures. These procedures, which include angioplasty and stent placement, are preferred due to their shorter recovery periods, reduced risk of infection, and less patient discomfort compared to traditional surgery. As these devices become more advanced, offering better precision and efficiency, healthcare providers in Saudi Arabia are increasingly opting for these less invasive options, aligning with the global shift towards patient-centric treatments.

Adoption of Drug-Eluting Devices

A key trend in the market is the rising adoption of drug-eluting devices, particularly drug-eluting stents and balloon catheters. These devices are designed to release medication that helps prevent restenosis, a common issue with traditional stents. The incorporation of drug-eluting technology has significantly improved patient outcomes by reducing the risk of vessel re-narrowing. As the benefits of drug-eluting devices become more widely recognized, they are expected to gain greater traction in the KSA market, particularly for treating complex vascular conditions.

Integration of Digital Technologies and AI in Vascular Care

The integration of digital technologies, including artificial intelligence (AI) and data analytics, is transforming the peripheral vascular devices market in Saudi Arabia. AI is being used to assist in the diagnosis and treatment planning of vascular diseases, enabling more accurate and efficient interventions. Additionally, digital tools such as wearable devices are being used to monitor patients post-treatment, ensuring better outcomes. As these technologies become more mainstream, they are expected to play an increasingly significant role in shaping the future of vascular care in Saudi Arabia.

Market Challenges Analysis

High Cost of Advanced Devices

One of the significant challenges in the KSA peripheral vascular devices market is the high cost associated with advanced medical devices. The latest innovations, such as drug-eluting stents and bioresorbable scaffolds, offer improved patient outcomes but come at a premium price. These costs can place a burden on both healthcare providers and patients, especially given the increasing demand for such advanced treatments. While government initiatives aim to reduce healthcare costs, the price of these specialized devices remains a barrier to widespread adoption, particularly in lower-income segments of the population. This challenge may hinder the rapid uptake of cutting-edge peripheral vascular devices in the broader Saudi market.

Limited Availability of Skilled Medical Personnel

Another challenge in the KSA peripheral vascular devices market is the limited availability of trained medical personnel, particularly vascular surgeons and interventional radiologists with expertise in using advanced peripheral vascular devices. While Saudi Arabia has made significant strides in improving its healthcare system, there remains a shortage of specialized healthcare providers in certain regions, limiting access to high-quality vascular care. For instance, Saudi Arabia needs an additional 175,000 healthcare professionals, including doctors, nurses, and allied health professionals, by 2030 to meet the growing demand. The need for additional training and education programs to upskill medical professionals is critical to ensuring that the benefits of new devices are fully realized. Without sufficient expertise in the latest technologies, the effective implementation of peripheral vascular devices may be compromised, thus affecting the market’s growth potential.

Market Opportunities

Expansion of Healthcare Infrastructure

A key market opportunity for peripheral vascular devices in Saudi Arabia lies in the continued expansion of the country’s healthcare infrastructure. Under the Vision 2030 initiative, Saudi Arabia is investing heavily in modernizing its healthcare system, including the development of specialized treatment centers for vascular diseases. This expansion is expected to increase the availability of advanced healthcare services across the nation, particularly in underserved regions. With enhanced infrastructure, healthcare providers will have the capacity to offer cutting-edge treatments for peripheral vascular conditions, which will drive demand for high-quality peripheral vascular devices. This growth in healthcare access presents a significant opportunity for companies to expand their product offerings and reach a broader patient base.

Rising Demand for Preventive and Early Treatment Solutions

The growing awareness about the importance of preventive healthcare and early diagnosis presents another key opportunity in the KSA peripheral vascular devices market. With increasing public awareness campaigns and a rising focus on healthcare education, more patients are seeking early interventions for vascular conditions. This shift toward prevention is leading to higher adoption rates of devices used for early-stage peripheral artery disease (PAD) management, such as diagnostic tools and minimally invasive treatments. Furthermore, as the government continues to emphasize preventive healthcare, the demand for advanced devices that offer faster recovery and fewer complications will grow. This trend creates an opportunity for market players to develop innovative solutions tailored to the needs of a proactive patient population, expanding their market share in the region.

Market Segmentation Analysis:

By Type:

The KSA peripheral vascular devices market is primarily segmented by type into angioplasty balloons, angioplasty stents, catheters, guidewires, and other devices. Angioplasty balloons hold a significant market share due to their widespread use in the treatment of peripheral artery diseases, as they are effective in opening blocked arteries. Angioplasty stents, particularly drug-eluting stents, are increasingly being adopted for their ability to prevent restenosis and improve long-term outcomes for patients. Catheters and guidewires are essential components in the successful performance of angioplasty and stent placement procedures. As minimally invasive techniques gain traction, these devices continue to witness strong demand. The “others” segment includes devices like atherectomy systems, which are gaining attention for treating more complex vascular conditions. The increasing preference for minimally invasive procedures and advanced technologies is driving the growth of these device segments, with a particular focus on innovation in stents and balloons to enhance patient outcomes and recovery times.

By End-user:

The market for peripheral vascular devices in Saudi Arabia is also segmented by end-user, including hospitals, ambulatory surgical centers (ASCs), and specialty clinics. Hospitals remain the largest end-user segment, as they offer comprehensive vascular care, including complex surgeries and advanced interventions. The growing number of hospitals in Saudi Arabia is boosting the demand for peripheral vascular devices, particularly in major cities. Ambulatory surgical centers are also emerging as a significant segment, driven by the growing trend of outpatient procedures that offer faster recovery times and cost-effective treatments. These centers are increasingly adopting minimally invasive devices, which are a key factor in expanding the market. Specialty clinics focusing on vascular health are becoming more prevalent, catering to the specific needs of patients with peripheral vascular diseases. As awareness of vascular conditions rises, these specialized clinics are likely to see continued growth, further driving demand for advanced peripheral vascular devices.

Shape Your Report to Specific Countries or Regions & Enjoy 30% Off!

Segments:

Based on Type:

  • Angioplasty Balloons
  • Angioplasty Stents
  • Catheters
  • Guidewires
  • Others

Based on End-user:

  • Hospitals
  • Ambulatory Surgical Centers
  • Specialty Clinics

Based on the Geography:

  • Central Region
  • Eastern Region
  • Western Region
  • Southern Region

Regional Analysis

Central Region

The Central Region holds the largest market share in the KSA peripheral vascular devices sector, representing approximately 35% of the total market. This is largely attributed to Riyadh’s status as the capital and a healthcare hub of the country. The region is home to numerous well-established hospitals, medical centers, and specialized clinics, which offer comprehensive vascular care and advanced surgical interventions. As the primary medical and educational center in Saudi Arabia, Riyadh attracts healthcare professionals and patients seeking high-quality treatments for vascular conditions. The region’s robust healthcare infrastructure and rising healthcare investments continue to drive the demand for advanced peripheral vascular devices, making it a key contributor to the market’s overall growth.

Eastern Region

The Eastern Region accounts for approximately 30% of the KSA peripheral vascular devices market. This region is home to key industrial cities such as Dammam, Khobar, and Jubail, which benefit from significant economic growth, particularly in the oil and gas sector. The increasing investment in healthcare infrastructure, coupled with rising awareness of vascular health, is propelling the demand for peripheral vascular devices. The region’s proximity to the Eastern Province’s industrial sectors has also led to better access to medical services, including the treatment of vascular diseases. The presence of leading hospitals and specialized centers for vascular care contributes to the region’s growing market share.

Western Region

The Western Region, including the cities of Jeddah and Mecca, holds a market share of approximately 20%. Jeddah, as a commercial and healthcare center, plays a crucial role in the region’s contribution to the peripheral vascular devices market. The region also benefits from the influx of pilgrims during the Hajj season, resulting in an increased demand for healthcare services, including vascular care. The Western Region is home to several prominent healthcare institutions and hospitals, which are expanding their vascular care capabilities to cater to a growing patient base. Additionally, government initiatives aimed at improving healthcare access further boost the market’s potential in this region.

Southern Region

The Southern Region holds a market share of around 15% in the KSA peripheral vascular devices market. This region, comprising cities such as Abha and Khamis Mushait, is seeing gradual growth in healthcare infrastructure and investment. While the market share is smaller compared to other regions, the Southern Region has substantial growth potential due to rising healthcare awareness and increasing demand for specialized vascular treatments. As the government continues to invest in improving healthcare access in rural and underserved areas, the demand for peripheral vascular devices is expected to grow steadily in the coming years. Local initiatives to improve diagnostic and treatment capabilities will also contribute to the region’s market expansion.

Key Player Analysis

  • Medtronic plc
  • Abbott Laboratories
  • Boston Scientific Corporation
  • Becton, Dickinson and Company
  • Terumo Corporation
  • Biotronik SE & Co. KG
  • Cook Medical
  • L. Gore & Associates, Inc.
  • Cardinal Health
  • AngioDynamics, Inc.

Competitive Analysis

The KSA peripheral vascular devices market is highly competitive, with leading players like Medtronic plc, Abbott Laboratories, Boston Scientific Corporation, Becton, Dickinson and Company, Terumo Corporation, Biotronik SE & Co. KG, Cook Medical, W. L. Gore & Associates, Inc., Cardinal Health, and AngioDynamics, Inc. Market leaders focus on continuous product development, with an emphasis on reducing treatment complications and enhancing patient outcomes. Key strategies employed by these companies include investing in research and development to advance technologies such as drug-eluting devices, bioresorbable stents, and minimally invasive procedures. Additionally, partnerships, collaborations, and acquisitions are commonly used to expand product portfolios and strengthen market presence. For example, the Ministry of Health in Saudi Arabia has concluded several cooperation agreements with international organizations to enhance healthcare services. Companies are also prioritizing the expansion of their distribution networks across Saudi Arabia, particularly in underserved regions, to capture new market opportunities. The focus on improving healthcare infrastructure and increasing patient awareness further intensifies competition. As the demand for more effective and less invasive vascular treatments grows, the competition is expected to intensify, with companies striving to develop products that offer quicker recovery times, better performance, and cost-effective solutions. With continuous advancements and strategic initiatives, market players are well-positioned to maintain their dominance in the growing peripheral vascular devices market in Saudi Arabia.

Recent Developments

  • In December 2024, Terumo Interventional Systems launched the R2P™ NaviCross® peripheral support catheter in the U.S. This catheter is designed for enhanced performance in radial-to-peripheral procedures, addressing the need for advanced tools in treating PAD and critical limb ischemia.
  • In October 2024, BD was highlighted as a key player in the peripheral vascular devices market forecast report. While specific recent product launches were not detailed, BD’s ongoing commitment to R&D and innovation positions it strongly within this competitive landscape.
  • In June 2023, Cook Medical announced new size options for its Advance Serenity PTA Balloon Catheter, used for treating peripheral artery disease (PAD).
  • In June 2023, Biotronik launched the Oscar multifunctional peripheral catheter, designed for dilation of stenotic segments in peripheral vessels. The device features user-adjustable components and aims to improve procedural efficiency in treating peripheral arterial disease.

Market Concentration & Characteristics

The KSA peripheral vascular devices market exhibits moderate concentration, with a few key players dominating the market landscape. However, there is still ample room for regional and local players to enter and gain market share through innovation and strategic partnerships. The market is characterized by a growing demand for advanced and minimally invasive devices, driven by the increasing prevalence of peripheral vascular diseases, particularly in an aging population. The key characteristics of this market include a strong focus on technological advancements, such as drug-eluting stents, bioresorbable scaffolds, and minimally invasive angioplasty devices, aimed at improving patient outcomes and reducing recovery times. As the demand for these devices rises, the competition is intensifying, with leading companies investing heavily in R&D to enhance device performance and efficacy. Additionally, the market is influenced by regulatory frameworks that ensure the safety and effectiveness of medical devices. Healthcare infrastructure development across Saudi Arabia, particularly in urban areas like Riyadh and Dammam, further supports the market’s growth. Another key feature is the increasing awareness and diagnosis of vascular diseases, encouraging the adoption of advanced devices. As healthcare providers continue to focus on offering high-quality vascular care, the market is expected to evolve, with both international and local companies vying for a larger share.

Report Coverage

The research report offers an in-depth analysis based on Type, End-user and Geography. It details leading market players, providing an overview of their business, product offerings, investments, revenue streams, and key applications. Additionally, the report includes insights into the competitive environment, SWOT analysis, current market trends, as well as the primary drivers and constraints. Furthermore, it discusses various factors that have driven market expansion in recent years. The report also explores market dynamics, regulatory scenarios, and technological advancements that are shaping the industry. It assesses the impact of external factors and global economic changes on market growth. Lastly, it provides strategic recommendations for new entrants and established companies to navigate the complexities of the market.

Future Outlook

  1. The increasing focus on reducing treatment costs will drive the demand for cost-effective vascular devices.
  2. Stronger collaborations between local and international medical device companies will enhance market offerings.
  3. Integration of artificial intelligence and robotics in vascular procedures will lead to improved outcomes and greater device demand.
  4. Regulatory improvements and streamlined approval processes will make it easier for new devices to enter the market.
  5. Saudi Arabia’s growing focus on non-invasive therapies will push the adoption of advanced vascular treatment technologies.
  6. The rise in chronic diseases, including diabetes, will contribute to the higher incidence of peripheral vascular diseases.
  7. The development of specialized vascular clinics will further promote the use of advanced peripheral vascular devices.
  8. Increased focus on patient-centric devices will shape future product innovations and patient care solutions.
  9. Growing demand for personalized medical treatments will lead to more tailored vascular solutions for patients.
  10. The shift towards outpatient care and ambulatory surgical centers will drive the demand for portable and less invasive vascular devices.

CHAPTER NO. 1 : INTRODUCTION 18
1.1.1. Report Description 18
Purpose of the Report 18
USP & Key Offerings 18
1.1.2. Key Benefits for Stakeholders 18
1.1.3. Target Audience 19
1.1.4. Report Scope 19

CHAPTER NO. 2 : EXECUTIVE SUMMARY 20
2.1. Peripheral Vascular Devices Market Snapshot 20
2.1.1. KSA Peripheral Vascular Devices Market, 2018 – 2032 (USD Million) 21

CHAPTER NO. 3 : GEOPOLITICAL CRISIS IMPACT ANALYSIS 22
3.1. Russia-Ukraine and Israel-Palestine War Impacts 22

CHAPTER NO. 4 : PERIPHERAL VASCULAR DEVICES MARKET – INDUSTRY ANALYSIS 23
4.1. Introduction 23
4.2. Market Drivers 24
4.2.1. Increasing prevalence of peripheral artery disease and other vascular conditions 24
4.2.2. Technological advancements in minimally invasive procedures 25
4.3. Market Restraints 26
4.3.1. High cost of peripheral vascular devices and associated procedures 26
4.4. Market Opportunities 27
4.4.1. Growing demand for peripheral vascular devices in emerging economies 27
4.5. Porter’s Five Forces Analysis 28
4.6. Buying Criteria 29

CHAPTER NO. 5 : IMPORT EXPORT ANALYSIS 30
5.1. Import Analysis by KSA 30
5.1.1. KSA Peripheral Vascular Devices Market Import Volume/Revenue, By KSA, 2018 – 2023 30
5.2. Export Analysis by KSA 31
5.2.1. KSA Peripheral Vascular Devices Market Export Volume/Revenue, By KSA, 2018 – 2023 31

CHAPTER NO. 6 : DEMAND SUPPLY ANALYSIS 32
6.1. Demand Analysis by KSA 32
6.1.1. KSA Peripheral Vascular Devices Market Demand Volume/Revenue, By KSA, 2018 – 2023 32
6.2. Supply Analysis by KSA 33
6.2.1. KSA Peripheral Vascular Devices Market Supply Volume/Revenue, By KSA, 2018 – 2023 33

CHAPTER NO. 7 : PRODUCTION ANALYSIS 34
7.1. Production Analysis by KSA 34
7.1.1. KSA Peripheral Vascular Devices Market Production Volume/Revenue, By KSA, 2018 – 2023 34

CHAPTER NO. 8 : PRICE ANALYSIS 35
8.1. Price Analysis by Type 35
8.1.1. KSA Peripheral Vascular Devices Market Price, By Type, 2018 – 2023 35
8.1.2. KSA Type Market Price, By Type, 2018 – 2023 35

CHAPTER NO. 9 : RAW MATERIALS ANALYSIS 36
9.1. Key Raw Materials and Suppliers 36
9.2. Key Raw Materials Price Trend 36

CHAPTER NO. 10 : MANUFACTURING COST ANALYSIS 37
10.1. Manufacturing Cost Analysis 37
10.2. Manufacturing Process 37

CHAPTER NO. 11 : ANALYSIS COMPETITIVE LANDSCAPE 38
11.1. Company Market Share Analysis – 2023 38
11.2. Value Chain Analysis 38
11.2.1. KSA Peripheral Vascular Devices Market: Company Market Share, by Volume, 2023 39
11.2.2. KSA Peripheral Vascular Devices Market: Company Market Share, by Revenue, 2023 40
11.2.3. KSA Peripheral Vascular Devices Market: Top 6 Company Market Share, by Revenue, 2023 40
11.2.4. KSA Peripheral Vascular Devices Market: Top 3 Company Market Share, by Revenue, 2023 41
11.3. KSA Peripheral Vascular Devices Market Company Volume Market Share, 2023 42
11.4. KSA Peripheral Vascular Devices Market Company Revenue Market Share, 2023 43
11.5. Company Assessment Metrics, 2023 43
11.5.1. Stars 43
11.5.2. Emerging Leaders 43
11.5.3. Pervasive Players 43
11.5.4. Participants 43
11.6. Start-ups /SMEs Assessment Metrics, 2023 43
11.6.1. Progressive Companies 43
11.6.2. Responsive Companies 44
11.6.3. Dynamic Companies 44
11.6.4. Starting Blocks 44
11.7. Strategic Developments 45
11.7.1. Acquisitions & Mergers 45
New Product Launch 45
KSA Expansion 45
11.8. Key Players Product Matrix 46

CHAPTER NO. 12 : PESTEL & ADJACENT MARKET ANALYSIS 47
12.1. PESTEL 47
12.1.1. Political Factors 47
12.1.2. Economic Factors 47
12.1.3. Social Factors 47
12.1.4. Technological Factors 47
12.1.5. Environmental Factors 47
12.1.6. Legal Factors 47
12.2. Adjacent Market Analysis 47

CHAPTER NO. 13 : PERIPHERAL VASCULAR DEVICES MARKET – BY TYPE SEGMENT ANALYSIS 48
13.1. Peripheral Vascular Devices Market Overview, by Type Segment 48
13.1.1. Peripheral Vascular Devices Market Revenue Share, By Type, 2023 & 2032 49
13.1.2. Peripheral Vascular Devices Market Attractiveness Analysis, By Type 50
13.1.3. Incremental Revenue Growth Opportunity, by Type, 2024 – 2032 50
13.1.4. Peripheral Vascular Devices Market Revenue, By Type, 2018, 2023, 2027 & 2032 51
13.2. Angioplasty Balloons 52
13.3. Angioplasty Stents 53
13.4. Catheters 54
13.5. Guidewires 55
13.6. Others 56

CHAPTER NO. 14 : PERIPHERAL VASCULAR DEVICES MARKET – BY END-USER SEGMENT ANALYSIS 57
14.1. Peripheral Vascular Devices Market Overview, by End-user Segment 57
14.1.1. Peripheral Vascular Devices Market Revenue Share, By End-user, 2023 & 2032 58
14.1.2. Peripheral Vascular Devices Market Attractiveness Analysis, By End-user 59
14.1.3. Incremental Revenue Growth Opportunity, by End-user, 2024 – 2032 59
14.1.4. Peripheral Vascular Devices Market Revenue, By End-user, 2018, 2023, 2027 & 2032 60
14.2. Hospitals 61
14.3. Ambulatory Surgical Centers 62
14.4. Specialty Clinics 63

CHAPTER NO. 15 : PERIPHERAL VASCULAR DEVICES MARKET – KSA ANALYSIS 64
15.1. Type 64
15.1.1. KSA Peripheral Vascular Devices Market Revenue, By Type, 2018 – 2023 (USD Million) 64
15.2. KSA Peripheral Vascular Devices Market Revenue, By Type, 2024 – 2032 (USD Million) 64
15.3. End-user 65
15.3.1. KSA Peripheral Vascular Devices Market Revenue, By End-user, 2018 – 2023 (USD Million) 65
15.3.2. KSA Peripheral Vascular Devices Market Revenue, By End-user, 2024 – 2032 (USD Million) 65

CHAPTER NO. 16 : COMPANY PROFILES 66
16.1. Medtronic plc 66
16.1.1. Company Overview 66
16.1.2. Product Portfolio 66
16.1.3. Swot Analysis 66
16.1.4. Business Strategy 67
16.1.5. Financial Overview 67
16.2. Abbott Laboratories 68
16.3. Boston Scientific Corporation 68
16.4. Becton, Dickinson and Company 68
16.5. Terumo Corporation 68
16.6. Biotronik SE & Co. KG 68
16.7. Cook Medical 68
16.8. W. L. Gore & Associates, Inc. 68
16.9. Cardinal Health 68
16.10. AngioDynamics, Inc. 68

List of Figures
FIG NO. 1. KSA Peripheral Vascular Devices Market Revenue, 2018 – 2032 (USD Million) 22
FIG NO. 2. Porter’s Five Forces Analysis for KSA Peripheral Vascular Devices Market 29
FIG NO. 3. KSA Peripheral Vascular Devices Market Import Volume/Revenue, By KSA, 2018 – 2023 31
FIG NO. 4. KSA Peripheral Vascular Devices Market Export Volume/Revenue, By KSA, 2018 – 2023 32
FIG NO. 5. KSA Peripheral Vascular Devices Market Demand Volume/Revenue, By KSA, 2018 – 2023 33
FIG NO. 6. KSA Peripheral Vascular Devices Market Supply Volume/Revenue, By KSA, 2018 – 2023 34
FIG NO. 7. KSA Peripheral Vascular Devices Market Production Volume/Revenue, By KSA, 2018 – 2023 35
FIG NO. 8. KSA Peripheral Vascular Devices Market Price, By Type, 2018 – 2023 36
FIG NO. 9. Raw Materials Price Trend Analysis, 2018 – 2023 37
FIG NO. 10. Manufacturing Cost Analysis 38
FIG NO. 11. Manufacturing Process 38
FIG NO. 12. Value Chain Analysis for KSA Peripheral Vascular Devices Market 39
FIG NO. 13. Company Share Analysis, 2023 40
FIG NO. 14. Company Share Analysis, 2023 41
FIG NO. 15. Company Share Analysis, 2023 41
FIG NO. 16. Company Share Analysis, 2023 42
FIG NO. 17. Peripheral Vascular Devices Market – Company Volume Market Share, 2023 43
FIG NO. 18. Peripheral Vascular Devices Market – Company Revenue Market Share, 2023 44
FIG NO. 19. Peripheral Vascular Devices Market Revenue Share, By Type, 2023 & 2032 50
FIG NO. 20. Market Attractiveness Analysis, By Type 51
FIG NO. 21. Incremental Revenue Growth Opportunity by Type, 2024 – 2032 51
FIG NO. 22. Peripheral Vascular Devices Market Revenue, By Type, 2018, 2023, 2027 & 2032 52
FIG NO. 23. KSA Peripheral Vascular Devices Market for Angioplasty Balloons, Revenue (USD Million) 2018 – 2032 53
FIG NO. 24. KSA Peripheral Vascular Devices Market for Angioplasty Stents, Revenue (USD Million) 2018 – 2032 54
FIG NO. 25. KSA Peripheral Vascular Devices Market for Catheters, Revenue (USD Million) 2018 – 2032 55
FIG NO. 26. KSA Peripheral Vascular Devices Market for Guidewires, Revenue (USD Million) 2018 – 2032 56
FIG NO. 27. KSA Peripheral Vascular Devices Market for Others, Revenue (USD Million) 2018 – 2032 57
FIG NO. 28. Peripheral Vascular Devices Market Revenue Share, By End-user, 2023 & 2032 59
FIG NO. 29. Market Attractiveness Analysis, By End-user 60
FIG NO. 30. Incremental Revenue Growth Opportunity by End-user, 2024 – 2032 60
FIG NO. 31. Peripheral Vascular Devices Market Revenue, By End-user, 2018, 2023, 2027 & 2032 61
FIG NO. 32. KSA Peripheral Vascular Devices Market for Hospitals, Revenue (USD Million) 2018 – 2032 62
FIG NO. 33. KSA Peripheral Vascular Devices Market for Ambulatory Surgical Centers, Revenue (USD Million) 2018 – 2032 63
FIG NO. 34. KSA Peripheral Vascular Devices Market for Specialty Clinics, Revenue (USD Million) 2018 – 2032 64

List of Tables
TABLE NO. 1. : KSA Peripheral Vascular Devices Market: Snapshot 21
TABLE NO. 2. : Drivers for the Peripheral Vascular Devices Market: Impact Analysis 25
TABLE NO. 3. : Restraints for the Peripheral Vascular Devices Market: Impact Analysis 27
TABLE NO. 4. : KSA Peripheral Vascular Devices Market Revenue, By Type, 2018 – 2023 36
TABLE NO. 5. : Key Raw Materials & Suppliers 37
TABLE NO. 6. : KSA Peripheral Vascular Devices Market Revenue, By Type, 2018 – 2023 (USD Million) 65
TABLE NO. 7. : KSA Peripheral Vascular Devices Market Revenue, By Type, 2024 – 2032 (USD Million) 65
TABLE NO. 8. : KSA Peripheral Vascular Devices Market Revenue, By End-user, 2018 – 2023 (USD Million) 66
TABLE NO. 9. : KSA Peripheral Vascular Devices Market Revenue, By End-user, 2024 – 2032 (USD Million) 66

 

Frequently Asked Questions

What is the current size of the KSA Peripheral Vascular Devices market?

The KSA Peripheral Vascular Devices market was valued at USD 18.47 million in 2023 and is projected to reach USD 25.29 million by 2032, growing at a compound annual growth rate (CAGR) of 4.00%.

What factors are driving the growth of the KSA Peripheral Vascular Devices market?

The market’s growth is driven by the rising prevalence of peripheral vascular diseases, advancements in minimally invasive medical technologies, increased healthcare infrastructure supported by the Vision 2030 initiative, and growing awareness of early diagnosis and treatment of vascular conditions.

What are the key segments within the KSA Peripheral Vascular Devices market?

The key segments include angioplasty balloons, angioplasty stents, catheters, guidewires, and other devices. End-users are divided into hospitals, ambulatory surgical centers, and specialty clinics, with hospitals holding the largest share due to their advanced infrastructure and comprehensive care capabilities.

What are some challenges faced by the KSA Peripheral Vascular Devices market?

Challenges include the high cost of advanced medical devices, which limits accessibility for lower-income populations, and a shortage of skilled medical professionals trained to use these devices, particularly in rural and underserved areas.

KSA Processed Beef Product Market

Published:
Report ID: 75592

Saudi Arabia (KSA) Air Traffic Market

Published:
Report ID: 74090

KSA Soldier Modernization Market

Published:
Report ID: 72901

KSA Police Modernization Market

Published:
Report ID: 71353

KSA Military Aircraft Modernization Market

Published:
Report ID: 70821

KSA Medical Gas and Equipment Market

Published:
Report ID: 70554

KSA Industry Vertical Modernization Services Market

Published:
Report ID: 70227

KSA Digital Radiography Market

Published:
Report ID: 69177

KSA Elevator Modernization Market

Published:
Report ID: 68343

South Africa Medical Gas and Equipment Market

Published:
Report ID: 75642

Compliance Monitoring Devices Market

Published:
Report ID: 75564

Continuous Glucose Monitoring Devices Market

Published:
Report ID: 4258

Internal Radiation Therapy Market

Published:
Report ID: 75411

Image Guided Radiotherapy Market

Published:
Report ID: 75382

Flat Panel X-Ray Detectors Market

Published:
Report ID: 74896

Hemostasis Testing Systems Market

Published:
Report ID: 74856

Cardiac Ultrasound Systems Market

Published:
Report ID: 74702

Aesthetic Medical Devices Market

Published:
Report ID: 74587

Italy Diabetes Care Devices Market

Published:
Report ID: 64898

Transplant Monitoring Kits Market

Published:
Report ID: 74464

Malignant Pleural Effusion Market

Published:
Report ID: 74366

Purchase Options

The report comes as a view-only PDF document, optimized for individual clients. This version is recommended for personal digital use and does not allow printing.
$2699

To meet the needs of modern corporate teams, our report comes in two formats: a printable PDF and a data-rich Excel sheet. This package is optimized for internal analysis and multi-location access, making it an excellent choice for organizations with distributed workforce.
$3699

The report will be delivered in printable PDF format along with the report’s data Excel sheet. This license offers 100 Free Analyst hours where the client can utilize Credence Research Inc.’s research team. It is highly recommended for organizations seeking to execute short, customized research projects related to the scope of the purchased report.
$5699

Smallform of Sample request

Have a question?

User Profile

Don’t settle for less – trust Mitul to help you find the best solution.

Report delivery within 24 to 48 hours

– Other Info –

What people say?-

User Review

I am very impressed with the information in this report. The author clearly did their research when they came up with this product and it has already given me a lot of ideas.

Jana Schmidt
CEDAR CX Technologies

– Connect with us –

Phone

+91 6232 49 3207


support

24/7 Research Support


sales@credenceresearch.com

– Research Methodology –

Going beyond the basics: advanced techniques in research methodology

– Trusted By –

Pepshi, LG, Nestle
Motorola, Honeywell, Johnson and johnson
LG Chem, SIEMENS, Pfizer
Unilever, Samsonite, QIAGEN